Article metrics

Original research
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis

 

Online download statistics by month:

Online download statistics by month: June 2023 to October 2024

AbstractFullPdf
Jun 2023628642157
Jul 202332432655
Aug 202321121224
Sep 202310610620
Oct 202312512933
Nov 202315015035
Dec 202310610766
Jan 202414014197
Feb 202411811973
Mar 2024123123224
Apr 2024909080
May 202411111587
Jun 2024909155
Jul 202410311278
Aug 2024697752
Sep 20245858835
Oct 202410910974
Total266127072045